0.8 ML epcoritamab-bysp 5 MG/ML Injection

Managing this medication for someone you care for? Eleplan keeps diagnoses, medications and appointments in one plan.

Start free with Eleplan

Clinical drug

0.8 ML epcoritamab-bysp 5 MG/ML Injection

5 MG/ML · Injection · injection

A form of epcoritamab-bysp →

0.8 ML epcoritamab-bysp 5 MG/ML Injection — Other monoclonal antibodies and antibody drug conjugates. Strength, form, class, interactions & more.

0.8 ML epcoritamab-bysp 5 MG/ML Injection

Active ingredient

Classification

Other monoclonal antibodies and antibody drug conjugatesBispecific CD20-directed CD3 T Cell Engager

Drug interactions

Epcoritamab-bysp may affect the metabolism of certain CYP substrates, leading to increased exposure and potential toxicity.

  • moderateCYP substrates — increased exposure leading to serious adverse reactions

Source: RxNorm + openFDA + RxClass + FAERS · 2026

Look up another medication

Powered by Eleplan

A drug lookup is just the start. Eleplan keeps the whole care plan in one place.

Medications, diagnoses, documents, appointments, and the whole care team — organized and always in sync, with Ellie, your AI care assistant, on top of it. Free to start.